{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:59:34Z","timestamp":1784609974499,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.psychres.2019.112523","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T10:56:20Z","timestamp":1566039380000},"page":"112523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review"],"prefix":"10.1016","volume":"280","author":[{"given":"Sam","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.112523_bib0001","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","article-title":"An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis","volume":"72","author":"Agid","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0002","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.euroneuro.2013.04.010","article-title":"Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching","volume":"23","author":"Agid","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbx021.052","article-title":"33. Clinical predictors of 2 types of treatment resistance in patients with psychosis","volume":"43","author":"Ajnakina","year":"2017","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.psychres.2019.112523_bib0004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291711001504","article-title":"Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years","volume":"42","author":"Alvarez-Jimenez","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbp129","article-title":"Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis","volume":"37","author":"\u00c1lvarez-Jim\u00e9nez","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112523_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2012.05.007","article-title":"Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies","volume":"139","author":"Alvarez-Jimenez","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0007","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.psychres.2019.112523_bib0008","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11126-016-9426-2","article-title":"A study of the impact of cannabis on doses of discharge antipsychotic medication in individuals with schizophrenia or schizoaffective disorder","volume":"87","author":"Babatope","year":"2016","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.psychres.2019.112523_bib0010","doi-asserted-by":"crossref","first-page":"e55821","DOI":"10.1371\/journal.pone.0055821","article-title":"Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings","volume":"8","author":"Batalla","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2019.112523_bib0011","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/schbul\/sbt065","article-title":"Life events and psychosis: a review and meta-analysis","volume":"39","author":"Beards","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112523_bib0012","doi-asserted-by":"crossref","first-page":"S690","DOI":"10.1016\/S0924-977X(16)31818-1","article-title":"Six-month outcome of patients with bipolar disorder and cannabis abuse following hospitalization for a first manic or mixed episode","volume":"26","author":"Bereza","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2014.11.018","article-title":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","volume":"25","author":"Bhattacharyya","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by\u03b49-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing","volume":"69","author":"Bhattacharyya","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by \u03949-tetrahydrocannabinol: a neural basis for the effects of cannabis sativa on learning and psychosis","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0016","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0033291713000433","article-title":"Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial","volume":"44","author":"Clausen","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0018","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.psychres.2018.08.005","article-title":"Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: a 6-year follow-up in an inpatient cohort","volume":"268","author":"Colizzi","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0019","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.schres.2015.11.016","article-title":"Substance use, medication adherence and outcome one year following a first episode of psychosis","volume":"170","author":"Colizzi","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2016.03.010","article-title":"Effect of cannabis on glutamate signalling in the brain: a systematic review of human and animal evidence","volume":"64","author":"Colizzi","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2019.112523_bib0021","article-title":"Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis","author":"Colizzi","year":"2019","journal-title":"Mol. Psychiatry."},{"issue":"56","key":"10.1016\/j.psychres.2019.112523_bib0022","doi-asserted-by":"crossref","DOI":"10.3310\/hta19560","article-title":"Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report","volume":"19","author":"Cooper","year":"2015","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.psychres.2019.112523_bib0023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction","volume":"57","author":"D'Souza","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0024","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40263-015-0269-4","article-title":"The use of continuous treatment versus placebo or intermittent treatment strategies in stabilized patients with schizophrenia: a systematic review and meta-analysis of randomized controlled trials with first-and second-generation antipsychotics","volume":"29","author":"De Hert","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2019.112523_bib0025","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0026","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.eurpsy.2016.01.820","article-title":"Brain glutamate levels and antipsychotic response in schizophrenia","volume":"33","author":"Egerton","year":"2016","journal-title":"Eur. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2019.112523_bib0027","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1017\/S0033291717000046","article-title":"Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis","volume":"47","author":"Foglia","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0028","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0029","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garcia","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/j.1440-1665.2005.02198.x","article-title":"Preventing episode II: relapse prevention in first-episode psychosis","volume":"13","author":"Gleeson","year":"2005","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123707","article-title":"Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis","volume":"10","author":"Gonz\u00e1lez-Ortega","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2019.112523_bib0032","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbp126","article-title":"Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use","volume":"37","author":"Gonz\u00e1lez-Pinto","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112523_bib0033","series-title":"Introduction to mediation, moderation, and conditional process analysis methodology: a regression-based approach","author":"Hayes","year":"2013"},{"key":"10.1016\/j.psychres.2019.112523_bib0086","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0034","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0035","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","article-title":"A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia","volume":"74","author":"Jauhar","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0036","article-title":"Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study","volume":"1","author":"Jauhar","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.comppsych.2009.03.008","article-title":"Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients","volume":"51","author":"Katz","year":"2010","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0038","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4306\/pi.2015.12.3.349","article-title":"Impact of cannabis use on long-term remission in bipolar i and schizoaffective disorder","volume":"12","author":"Kim","year":"2015","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.psychres.2019.112523_bib0039","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/15299732.2015.1089969","article-title":"Posttraumatic stress symptoms (PTSS) in caregivers of people with psychosis and associations with caregiving experiences","volume":"17","author":"Kingston","year":"2016","journal-title":"J. Trauma Dissociation"},{"key":"10.1016\/j.psychres.2019.112523_bib0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3111\/13696998.2013.841705","article-title":"Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics","volume":"16","author":"Lafeuille","year":"2013","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.psychres.2019.112523_bib0041","doi-asserted-by":"crossref","first-page":"S819","DOI":"10.1016\/j.eurpsy.2017.01.1595","article-title":"Remission and recovery from first-episode psychosis in adults: a systematic review and meta-analysis of long-term outcome studies","volume":"41","author":"Lally","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0042","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.psychres.2019.112523_bib0043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet North Am. Ed."},{"issue":"10","key":"10.1016\/j.psychres.2019.112523_bib0044","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0045","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.psychres.2019.112523_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0047","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.biopsych.2015.11.013","article-title":"The role of cannabinoids in neuroanatomic alterations in cannabis users","volume":"79","author":"Lorenzetti","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0048","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2017.03.030","article-title":"Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: a randomized fMRI study","volume":"194","author":"Machielsen","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0049","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pnpbp.2010.11.007","article-title":"Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency","volume":"35","author":"Makkos","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0050","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/0004867412440192","article-title":"Does giving up substance use work for patients with psychosis? A systematic meta-analysis","volume":"46","author":"Mullin","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0051","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0004867415599846","article-title":"Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use","volume":"50","author":"Myles","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0052","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1185\/03007991003658956","article-title":"Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective","volume":"26","author":"Nicholl","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.psychres.2019.112523_bib0053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/acps.12954","article-title":"Clozapine as a first\u2010or second\u2010line treatment in schizophrenia: a systematic review and meta\u2010analysis","volume":"138","author":"Okhuijsen\u2010Pfeifer","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112523_bib0054","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"6","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2019.112523_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0033291713000330","article-title":"Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis","volume":"44","author":"Pelayo-Teran","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0056","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2008.00074.x","article-title":"Epidemiological factors associated with treated incidence of first\u2010episode non\u2010affective psychosis in Cantabria: insights from the clinical programme on early phases of psychosis","volume":"2","author":"Pelayo\u2010Ter\u00e1n","year":"2008","journal-title":"Early Interv. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.112523_bib0057","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ajp.2012.12060778","article-title":"Clozapine's role in the treatment of first-episode schizophrenia","volume":"170","author":"Remington","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0058","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0033291715002342","article-title":"Effect of high-potency cannabis on corpus callosum microstructure","volume":"46","author":"Rigucci","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0059","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/pcn.12085","article-title":"Is cannabis neurotoxic for the healthy brain? A meta\u2010analytical review of structural brain alterations in non\u2010psychotic users","volume":"67","author":"Rocchetti","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2019.112523_bib0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0061","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0062","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.euroneuro.2015.03.011","article-title":"Does cannabis affect dopaminergic signalling in the human brain? A systematic review of evidence to date.","volume":"25","author":"Sami","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0063","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/0269881118760662","article-title":"Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.","volume":"32","author":"Sami","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0064","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eurpsy.2011.03.001","article-title":"Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis","volume":"27","author":"Schimmelmann","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0066","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0067","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2215-0366(17)30233-X","article-title":"Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis","volume":"4","author":"Schoeler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0068","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.psychres.2017.05.009","article-title":"Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis","volume":"255","author":"Schoeler","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0069","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","article-title":"Association between continued cannabis use and risk of relapse in first-episode psychosis: a quasi-experimental investigation within an observational study","volume":"73","author":"Schoeler","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK national Eden study","volume":"42","author":"Seddon","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112523_bib0071","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/phar.1747","article-title":"Treatment of cannabis use disorder: current science and future outlook","volume":"36","author":"Sherman","year":"2016","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.psychres.2019.112523_bib0072","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00127-016-1222-7","article-title":"Wellbeing, mental health knowledge and caregiving experiences of siblings of people with psychosis, compared to their peers and parents: an exploratory study","volume":"51","author":"Sin","year":"2016","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2019.112523_bib0073","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S2045796016000305","article-title":"Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 national survey of high impact psychosis","volume":"26","author":"Siskind","year":"2017","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.psychres.2019.112523_bib0074","article-title":"Clozapine treatment and cannabis use in adolescents with psychotic disorders \u2013 a retrospective cohort chart review","volume":"26","author":"Tang","year":"2017","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2019.112523_bib0075","first-page":"347","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"75","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.112523_bib0076","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"Van der Meer","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2019.112523_bib0077","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/PPA.S124658","article-title":"why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.","volume":"11","author":"Velligan","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.psychres.2019.112523_bib0078","first-page":"653","article-title":"Evidence-based treatment options in cannabis dependency","volume":"113","author":"Walther","year":"2016","journal-title":"Dtsch. Arztebl Int."},{"key":"10.1016\/j.psychres.2019.112523_bib0079","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/schbul\/sbw179","article-title":"The effect of substance use on 10-year outcome in first-episode psychosis","volume":"43","author":"Weibell","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112523_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0269881115612237","article-title":"Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: a systematic review","volume":"30","author":"Wilson","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0081","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","year":"1992"},{"key":"10.1016\/j.psychres.2019.112523_bib0082","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112523_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis","author":"Zhu","year":"2017","journal-title":"European Neuropsychopharmacology."},{"key":"10.1016\/j.psychres.2019.112523_bib0084","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","article-title":"Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review","volume":"152","author":"Zipursky","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112523_bib0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/acps.12366","article-title":"Cannabis and bipolar disorder: does quitting cannabis use during manic\/mixed episode improve clinical\/functional outcomes?","volume":"131","author":"Zorrilla","year":"2015","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119311849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119311849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:35:23Z","timestamp":1759037723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119311849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":86,"alternative-id":["S0165178119311849"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112523","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112523"}}